Circulatory Improvement Agent

Circulatory Improvement Agent


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
Category
Herbal Medicine
tK Meet
tK Meet

Apply a video call to the Supplier

SEND TO SUPPLIER INQUIRY

Myungmoon Pharm. Co., Ltd.

Country / Year Established
South Korea South Korea /
Business type
Others
Verified Certificate

16

TRADE TOWER

DUNS

Product name Circulatory Improvement Agent Certification -
Category Herbal Medicine Ingredients -
Keyword - Unit Size -
Brand name - Unit Weigh -
origin Stock -
Supply type - HS code -

Product Information

Meprodil inj.(Buflomedil HCL 50mg)

Composition : One ampoule(5ml) contains
Buflomedil.HCI - 50mg

Indication & Usage :

  • Periphery circulation disorder : Raynaud’s disease, Intermittent claudication
  • Buerger's disease

Dosage & Administration :

  • I.V, I.M : 50mg per one time, Two times a day.
  • Dextrose Inj. Sodium Chloride Inj. : 100mg ~ 400mg a day.

Package : 5ml/Amp x 10

 
Mezofyllin Inj.(Pentoxifylline 100mg)

Composition : One ampoule(5ml) contains
Pentoxifylline - 100mg

Indication & Usage :

  • Brain circulation disorder
  • For the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. This drug can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.

Dosage & Administration

  • Intravenous Injection : 100mg a day. At the first time, dilute 50mg in the sodium chloride up to 10ml.
  • Intravenous Drip Injection : 100mg a day, Dilute 100mg in 250ml ~ 500ml Sodium Chloride or etc and Inject it for 90 to 180 minutes.
  • Increase 50mg a day up to 300mg.
  • Artery Injection : Using motor-driven syringe, administer 100mg ~ 300mg diluted in Sodium Chloride 20ml ~ 50ml a day

Package : 5ml/Amp x 10

 
Proben Inj.(Melilotus Ext. 300mg, Proxyphylline 240mg)

Composition : One ampoule(2ml) contains
Melilotus ext. - 300mg
Proxyphylline - 240mg

Indication & Usage :
Cerebrovascular and peripheral disorder diseases, Traumas(sprain, fracture, bruise, contusion), inflammations due to soft tissue swelling after surgery

Dosage & Administration :
Cerebrovascular and peripheral disorder diseases : 1 to 2 amp. three times a day. Traumas(sprain, fracture, bruise, contusion), inflammations due to soft tissue swelling after surgery : 1 to 2 amp. three times a day, I.M.

Package : 2ml/Amp x 50

 
Cartin Inj.(L-Carnitine 1,000mg/5ml)

Composition : One ampoule(5ml) contains
L-Carnitine - 1,000mg

Indication & Usage :
For the acute and chronic treatment of patients with an inborn error of metabolism that in secondary carnitine deficiency.

Dosage & Administration

  • The recommended dose is 50mg/kg given as a slow 2-3 minute bolus injection or by infusion. All subsequent daily doses are recommended to be in the range of 50mg/kg or as therapy may require.
  • The highest dose administered has been 300mg/kg.

Package : 5ml/Amp x 10

 
Cartin Tab.(L-Carnitine 330mg)

Composition : One tablet contains
L-Carnitine - 330mg

Indication & Usage :

  • Dietary supplementation of L-Carnitine for renal patients. Because of dietary restrictions and other factors renal dialysis patients have a limited intake of this essential nutrient.
  • Obesity.

Dosage & Administration

2~3g daily, two times ~ three time divided

Package : 5ml/Amp x 10

 
Neocoline Inj. 500mg(Citicoline 500mg/2ml)

Composition : One ampoule contains
Citicoline - 500mg

Indication & Usage, Dosage & Administration

  • Stupor caused by head trauma and cerebral surgery : 100~500mg per dose 1~2 daily by I.M. or I.V.
  • Concomitant therapy with anticholinergic agent for parkinson disease : 1ampoule per dose once a day for 3~4 weeks by I.V.
  • Hemiplegia after cerebral apoplexy : 1000mg or 250mg per dose once a day for 4 weeks by I.V.
  • Pancreatitis : 100mg per dose once a day for 2 weeks by I.V.
  • Refer to insert-paper for further information

Package : 10 Ampoules/Box.

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

Myungmoon Pharm. Co., Ltd.

Country / Year Established
South Korea South Korea /
Business type
Others

16

TRADE TOWER

DUNS

President
LEE, GYU HUOK
Address
Myungmoon B/D, 946-18, Dokok-Dong, Gangnam-Ku, Korea
Product Category
Beauty & Personal Care,Chemical & Pharmaceutical Machinery,Pharmaceuticals
No. of Total Employees
101-500
Company introduction

In 1983, Myungmoon Pharm. Co., Ltd. was established for the improvement of national health. It is achieving remarkable development via research and development, production, and sales based on its founding principle: Advancement, Harmony, and Creation. Myungmoon Pharm. Co., Ltd. is an acknowledged manufacturer to produce the finished medicines; Injection, Tablet, Capsule, Patches, Solution and Creams.

Nowadays, Myungmoon Pharm. Co., Ltd. produces more than 250 specialized and general medicines and has more than 400 specialized and generalmedicine licenses to be able to manufacture. Myungmoon Pharm. Co., Ltd. is focusing on our research and development efforts so that Myungmoon Pharm. Co., Ltd. is launching more than 20 new products every year.

Myungmoon Pharm. Co., Ltd. established the new plant for API in 2008. Myungmoon Pharm. Co., Ltd has Gabapentin(USP) and the other 8 API products now, however, Myungmoon Pharm. Co., Ltd. would have many new API products in the foreseeable future. To gain a foothold on biomedicine products, outsourcing strategies are preceding the use of trusted clinical agency CRO and production agency CMO, and Myungmoon Pharm. Co., Ltd has already started to develop human growth hormones through a bio-venture corporation. Within 2 or 3 years, Myungmoon Pharm. Co., Ltd. should be launching bio-similar, including EPO and the processing of the complement of plants for biomedical products as well as the development of advanced medical bioethics, including monoclonal antibodies.

Myungmoon Pharm. Co., Ltd. is sharply developing to be a professional and global treatment company in the world.

Main Markets

China China

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My tK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more